Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice

PloS One
Yuling ChiVictor L Schuster

Abstract

Inhibiting the synthesis of endogenous prostaglandins with nonsteroidal anti-inflammatory drugs exacerbates arterial hypertension. We hypothesized that the converse, i.e., raising the level of endogenous prostaglandins, might have anti-hypertensive effects. To accomplish this, we focused on inhibiting the prostaglandin transporter PGT (SLCO2A1), which is the obligatory first step in the inactivation of several common PGs. We first examined the role of PGT in controlling arterial blood pressure blood pressure using anesthetized rats. The high-affinity PGT inhibitor T26A sensitized the ability of exogenous PGE2 to lower blood pressure, confirming both inhibition of PGT by T26A and the vasodepressor action of PGE2 T26A administered alone to anesthetized rats dose-dependently lowered blood pressure, and did so to a greater degree in spontaneously hypertensive rats than in Wistar-Kyoto control rats. In mice, T26A added chronically to the drinking water increased the urinary excretion and plasma concentration of PGE2 over several days, confirming that T26A is orally active in antagonizing PGT. T26A given orally to hypertensive mice normalized blood pressure. T26A increased urinary sodium excretion in mice and, when added to the mediu...Continue Reading

References

Nov 1, 1979·Journal of Medicinal Chemistry·T K Schaaf, H J Hess
Mar 1, 1978·Circulation Research·E D VaughanC R Ayers
Jun 1, 1992·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Y UeharaT Sugimoto
Jan 17, 1986·The American Journal of Medicine·K H Raymond, M D Lifschitz
Apr 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M C Smith, M J Dunn
Dec 1, 1984·Prostaglandins·D J HeaveyC T Dollery
May 12, 1995·Science·N KanaiVictor L Schuster
Jan 19, 1995·The American Journal of Cardiology·J R Vane, R M Botting
Aug 15, 1994·Annals of Internal Medicine·A G JohnsonR O Day
Feb 22, 1993·Archives of Internal Medicine·J E PopeD T Felson
Sep 1, 1996·The Journal of Clinical Investigation·Run LuVictor L Schuster
Apr 29, 1998·Annual Review of Physiology·Victor L Schuster
Apr 15, 1999·Nature Medicine·A M WattsR C Kennedy
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·S M McCormickK K Chittur
Aug 7, 2002·British Journal of Pharmacology·Klaus HöcherlArmin Kurtz
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Victor L Schuster
Feb 14, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Steven E WhitesallLouis G D'Alecy
Jan 7, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Hidetsuna WatanabeTsuyoshi Watanabe
Feb 16, 2005·Archives of Internal Medicine·Tai-Juan AwHenry Krum
Feb 18, 2005·Gene·Jih-Tung Pai, Erkki Ruoslahti
Feb 19, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bing YaoMing-Zhi Zhang
Sep 13, 2005·Cell Metabolism·Helene FrancoisThomas M Coffman
Sep 29, 2005·American Journal of Physiology. Renal Physiology·Wenling YeTianxin Yang
Nov 5, 2005·The Journal of Pharmacology and Experimental Therapeutics·Yuling ChiVictor L Schuster

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
M C Smith, M J Dunn
Schweizerische medizinische Wochenschrift
L Favre, M B Vallotton
© 2021 Meta ULC. All rights reserved